ELISPOT cell rescue
- 1 May 2004
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 288 (1-2) , 135-147
- https://doi.org/10.1016/j.jim.2004.03.006
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Use of interleukin 15 to enhance interferon-γ production by antigen-specific stimulated lymphocytes from rhesus macaquesJournal of Immunological Methods, 2003
- Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+T Cells in Primary HIV-1 InfectionJournal of Virology, 2003
- Immunogenicity of a Recombinant Human Immunodeficiency Virus (HIV)–Canarypox Vaccine in HIV‐Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine StudyThe Journal of Infectious Diseases, 2003
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral TherapyAIDS Research and Human Retroviruses, 2002
- Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cellsAIDS, 2002
- Monitoring HIV-specific CD8+ T cell responses by intracellular cytokine productionImmunology Letters, 2001
- The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccinesCancer Immunology, Immunotherapy, 2000
- Shipment Impairs Lymphocyte Proliferative Responses to Microbial AntigensClinical and Diagnostic Laboratory Immunology, 2000
- HLA and HIV-1: Heterozygote Advantage and B*35 - Cw*04 DisadvantageScience, 1999